Regulatory Submission Gap Analysis: Process, Benefits and Best Practices
Regulatory submission gap analysis helps pharmaceutical companies check their regulatory documents against health authority requirements before submitting an application. It identifies missing information, inconsistencies, and areas that need improvement. Conducting this assessment early helps improve submission readiness, strengthen documentation quality, and address potential regulatory concerns before the dossier reaches the reviewing authority.
What Is Regulatory Submission Gap Analysis?
Regulatory submission gap analysis is a systematic review of a pharmaceutical dossier to determine whether the available documents meet the requirements of the relevant regulatory authority. It typically covers quality, clinical, non-clinical, manufacturing, and administrative documentation in line with applicable regulatory guidelines and submission formats.
Key Steps in the Gap Analysis Process
A structured assessment generally involves the following steps:
Requirement Assessment: Identify applicable regulatory guidelines and the specific requirements for the planned submission.
Document Review: Examine the available dossier sections and supporting documents for completeness and consistency.
Gap Identification: Highlight missing information, incomplete sections, outdated records, and inconsistencies.
Impact Assessment: Evaluate how identified gaps could affect regulatory compliance and submission readiness.
Corrective Action Planning: Define the actions required to address each gap, along with responsibilities and target completion dates.
Benefits of Regulatory Submission Gap Analysis
A thorough assessment improves documentation quality, identifies potential compliance risks, and supports effective regulatory planning. It helps companies prioritise corrective actions, minimise avoidable submission deficiencies, and prepare more complete regulatory dossiers. Early identification of gaps can also support better coordination between regulatory, quality, clinical, and manufacturing teams.
Best Practices for Effective Gap Analysis
Use current regulatory guidelines, maintain an organised document checklist, involve relevant subject-matter experts, and record findings systematically. Each identified gap should have a clearly defined corrective action, an assigned owner, and a target completion date. Regular reviews help ensure that documentation remains aligned with applicable regulatory expectations.
How MASUU Global Can Support
MASUU Global supports pharmaceutical companies with regulatory documentation review, dossier gap assessment, submission preparation, and regulatory strategy. A structured assessment helps organisations improve dossier completeness, address documentation gaps, and strengthen overall submission readiness.
Identifying and resolving documentation gaps early can make the regulatory submission process more organised and efficient, helping companies prepare their applications with greater clarity and confidence.